Who is the CEO of Chemkart India Ltd?
- Answer Field
-
The CEO of Chemkart India Limited is Ankit Shailesh Mehta.
BAJAJ BROKING
Chemkart India Limited, incorporated in 2015, operates as a B2B distributor of food and health ingredients. With a focus on bridging the gap between global ingredient manufacturers and businesses in sectors such as sports nutrition, health supplements, and protein-based products, the company has established itself as an integral part of the nutritional supply chain. It offers a mix of grinding, blending, and packaging services at its dedicated facility in Bhiwandi, Mumbai, spread across 28,259.16 sq. ft., allowing for smooth operations in ingredient handling, labelling, and sealing.
The company’s portfolio includes seven product categories: Amino Acids, Health Supplements, Herbal Extracts, Nucleotides, Proteins, Sports Nutrition, and Vitamins. These ingredients are used across products supporting metabolism, immunity, athletic performance, and overall health. Headquartered in Mumbai and supported by a team of 40 employees (as of March 31, 2025), Chemkart is positioned to meet the increasing demand for nutrition-focused food solutions.
For more details, visit the Chemkart India IPO page.
Details | Information |
IPO Date | July 7, 2025 to July 9, 2025 |
Issue Size | 32,29,200 shares (aggregating up to ₹80.08 Cr) |
Price Band | ₹236 to ₹248 per share |
Lot Size | 600 shares |
Listing At | BSE SME |
Market maker | Alacrity Securities Ltd. |
Financing the capital expenditure towards setting up of the Manufacturing Facility through investment in our Wholly-Owned Subsidiary (WOS) Company, Easy Raw Materials Private Limited
Repayment/prepayment of all or certain of our borrowings availed of by our Company
General Corporate Purpose
Event | Date |
---|---|
IPO Open Date | Mon, Jul 7, 2025 |
IPO Close Date | Wed, Jul 9, 2025 |
Tentative Allotment | Thu, Jul 10, 2025 |
Initiation of Refunds | Fri, Jul 11, 2025 |
Credit of Shares to Demat | Fri, Jul 11, 2025 |
Tentative Listing Date | Mon, Jul 14, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on July 9, 2025 |
₹236 to ₹248 per share
Application | Lots | Shares | Amount |
Individual investors (Retail) (Min) | 2 | 1,200 | ₹2,97,600 |
Individual investors (Retail) (Max) | 2 | 1,200 | ₹2,97,600 |
HNI (Min) | 3 | 1,800 | ₹4,46,400 |
Log in to Your Trading Account
Access your trading account through your broker’s platform.
Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Select Chemkart India IPO
Find "Chemkart India IPO" and click on the ‘Apply’ button.
Enter Application Details
Specify the number of lots (minimum lot size: 600 shares) and the bid price within the range of ₹236 to ₹248 per share.
Provide Your UPI ID
Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.
Review and Submit
Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on July 9, 2025, to complete your application process.
Total Assets: Grew from ₹37.48 crore in FY23 to ₹86.12 crore as of March 2025.
Revenue: Reached ₹205.46 crore in FY25.
Profit After Tax (PAT): Stood at ₹24.26 crore for March 2025.
Net Worth: Recorded at ₹53.29 crore in FY25.
Reserves and Surplus: Recorded at ₹43.79 crore (March 2025), growing steadily over the years.
Total Borrowings: Stood at ₹17.03 crore in March 2025.
The company has witnessed consistent growth in its total assets over recent financial years.
Revenue generation has shown an upward trend, reflecting increased business activity and demand.
Profitability has improved, indicating operational efficiency and effective cost management.
The company’s net worth has strengthened, highlighting a more stable financial position.
Reserves and surplus have grown steadily, contributing to a healthier balance sheet.
Borrowings are present but appear to be managed in line with overall business expansion.
These indicators suggest a positive outlook with scope for sustained growth across core business areas.
The company operates in a niche B2B segment, and its performance may be affected by fluctuations in demand from specific sectors like sports nutrition and health supplements.
Expansion plans, including setting up a new manufacturing facility through a subsidiary, may face delays or unforeseen challenges that could impact future operations.
The company’s diverse product portfolio and integrated services (grinding, blending, and packaging) position it to benefit from the rising demand for nutrition-based food and health products.
Planned investments in infrastructure and capital expenditure indicate a forward-looking approach that may support long-term scalability and market expansion.
KPI | Values |
ROE | 59% |
ROCE | 49% |
Debt/Equity | 0.32 |
RoNW | 45.52% |
EBITDA Margin | 16.12% |
Price to Book Value | 8.12 |
Registrar | Lead Manager(s) |
---|---|
Bigshare Services Pvt Ltd | Smart Horizon Capital Advisors Private Limited |
Chemkart India Limited
Office No. 403/404,
4th Floor, K.L. Accolade, 6th Road,
TPS III, Santacruz (East),
Mumbai, Maharashtra, 400055
Phone: +91 9136383828
Email: investors@chemkart.com
Website: https://chemkart.com/
Chemkart India Limited operates in the B2B distribution space, supplying food and health ingredients across several sectors. With a facility in Mumbai and a product range that includes amino acids, proteins, vitamins, and more, the company supports various manufacturing requirements in health and nutrition-related industries. It also offers processing services such as grinding, blending, and packaging.
The IPO aims to raise funds for capital expenditure, debt repayment, and general corporate purposes. Investors may review the company’s operations, sector presence, and financial performance to understand its current positioning. Further insights can be obtained from the official Chemkart India IPO page.
Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Chemkart India IPO.
Share this article:
No result found
The CEO of Chemkart India Limited is Ankit Shailesh Mehta.
The Chemkart India IPO is scheduled to open on July 7, 2025, and will close on July 9, 2025.
Chemkart India Limited operates as a B2B distributor of food and health ingredients. The company offers products such as amino acids, proteins, herbal extracts, and vitamins, with additional services like grinding, blending, and packaging. The business caters to ongoing demand for nutrition-based products, and its model depends on factors such as sector-specific demand, supply chain consistency, and operational efficiency.
The IPO issue size is 32,29,200 shares, aggregating up to ₹80.08 crore.
‘Pre-apply’ allows investors to submit their IPO application in advance of the official opening date. The application is processed once the IPO officially opens for public subscription.
You will receive a confirmation via your broker’s platform and a UPI mandate request once your IPO order is placed. Final status is updated after approval of the UPI mandate and submission before the deadline.
The minimum lot size for the Chemkart India IPO is 600 shares. Retail investors must apply for a minimum of 2 lots (1,200 shares).
The tentative allotment date for the Chemkart India IPO is July 10, 2025.
The registrar for the Chemkart India IPO is Bigshare Services Pvt Ltd.
As per the available public disclosures, there are no governance-related red flags or reported issues concerning the company’s leadership or board structure.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading